Technical Center

White Papers

Blood Culture

(Click column headings to sort items)

Description Year Literature # Comparative Study of the Instrument Robustness of Automated Blood Culture Devices: BD BACTEC™ versus bioMérieux BacT/Alert™ 2007 LR222669 Differences in Time to Detection and Recovery of Mycobacterium tuberculosis between the MGIT 960 and the BacT/Alert MB Automated Culture Systems. 2007 LR222668 Effectiveness of the BACTEC™ Blood Culture Resin-based Antimicrobial Removal System with Fluoroquinolones, Antifungals, Daptomycin, Tigecycline and Polymyxin B. 2006 LR222473 Ability of BD BACTEC Plus Blood Culture Bottles versus BacT/Alert FAN Blood Culture Bottles to Detect Bacterial Pathogens in Samples Containing Therapeutic Levels of Cefoxitin and Piperacillin/Tazobactam 2005 LR222337 Ability of BD BACTEC Plus Blood Culture Bottles versus BacT/Alert FAN Blood Culture Bottles to Detect Bacterial Pathogens in Samples Containing Vancomycin 2005 LR891 Blood Culture Antimicrobial Removal Effectiveness of BD BACTEC Plus Media Versus BacT/ALERT FAN Media 2003 LR789 Advanced Interactive Epidemiology Reports utilizing the BD Phoenix™ EpiCenter™ System 2000 LR644 Incidence of Safe Sample Collection Procedures with the BacT/Alert™ Blood Culture System LR848 Improving Sepsis Diagnosis: Key to Better Patient Outcomes, Higher Reimbursement LR888

Collection and Transport

(Click column headings to sort items)

Description Year Literature # Comparative Study of the Viability of Clinically Important Bacteria in Two New Amies Gel Transport Systems (BD CultureSwab™ MaxV(+) and Remel BactiSwab) Using NCCLS M40 - A Quantitative Swab Elution Method. 2005 LR222318 Comparative Evaluation of Two New Amies Swab Transport Systems BD CultureSwab™ Max V(+) (Copan) and the Fisherfinest® (Starplex) Swab 2005 LR222317 Comparison of StarSwab II with BD CultureSwab™ Max V(+) Transport Systems for Preservation of Bacterial Pathogens Important in Pediatric Medicine; Hemophilus influenza, Streptococcus pneumoniae,and Neisseria meningitidis 2005 LR222319 Modification of Swab Applicators Providing Full Compliance with NCCLS Standard M40-A 2004 LR222316 Influence of Storage Conditions on the Performance of Swab Transport Devices as Determined by the Quality Control Guidelines of NCCLS Standard M40 2004 LR222315 A Comparison of Two Swab Transport Systems in the Recovery of Fastidious Organisms 2004 LR222314

Dehydrated Culture Media

(Click column headings to sort items)

Description Year Literature # A Rapid and Effective Screening Process of Animal Component Free Hydrolysates to Increase Cell Performance 2004 LR876

Direct Testing / Serology

(Click column headings to sort items)

Description Year Literature # Comparison of BD Directigen™ EZ RSV and Remel X/pect™ RSV Rapid Chromatographic Immunoassays to Direct Immunofluorescence for Detection of Respiratory Syncytial Virus in Pediatric Patients 2006 LR222659 Comparison of Rapid Influenza Antigen Kits for Analytical Sensitivity and Compatibility with Viral Transport Medium. 2006 LR222254 Evaluation of the BD Directigen™ EZ Flu A+B Rapid Chromatographic Immunoassay 2005 LR904 The Effect of Various Swab Types on the Performance of the BD Directigen™ EZ FLU A+B Test and Three Other Rapid Chromatographic Immunoassay 2005 LR919 Evaluation of Lateral Flow and Membrane Flow Immunoassays for the Rapid Detection of Influenza A and Influenza B Viruses 2005 LR911 Specific Detection of Influenza A and B Virus Strains and Analytical Sensitivity Using the Directigen™ Flu A+B Test 2001 LR695 Performance of the Directigen™ Flu A+B Test Using Clinical Specimens from November 1999 to March 2000 2001 LR694 Evaluation of Influenza A and B Virus Storage Stability in M5 Transport Medium Using the Directigen™ Flu A+B Test 2001 LR696

Identification / Susceptibility

(Click column headings to sort items)

Description Year Literature # BD EpiCenter™ and Bruker MALDI Biotyper Integration Pilot Study 2011 LR223494 Evaluation of the Becton Dickinson Phoenix and bioMérieux VITEK Legacy Automated Microbiology Identification and Antimicrobial Susceptibility Systems. 2006 LR222447 Evaluation of the BD Phoenix™ Automated Microbiology System for Antibiotic Susceptibility Testing of Streptococcus pneumoniae 2006 LR222403 Direct Comparison of the BD Phoenix™ Automated Microbiology System with the Microscan Walkaway for Identification and Antimicrobial Susceptibility Testing of Staphylococci, Enterococci, and Antimicrobial Susceptibilityof Streptococci. 2006 LR222405 Direct Comparison of Antimicrobial Susceptibility Testing by the BD Phoenix, bioMérieux ViTek 2, and Disk Diffusion Test Methods as Compared to Results Generated by the CLSi Broth Microdilution Test 2006 LR222449 Comparative Study of Identification and Antimicrobial Susceptibility Testing of Enterobacteriaceae and Non-Fermentative Gram-Negative Organisms with the Phoenix™ Automated Microbiology System and Microscan Walkaway. 2006 LR222406 Comparison of Phoenix and Vitek 2 ESBL Confirmatory Tests Against E. coli and Klebsiella Isolates with Well-characterized β-lactamases 2006 LR222404 Evaluation of the BD Phoenix™ for Routine Use in a Tertiary-Care Hospital Microbiology Laboratory 2005 LR886 Evaluation of BD Phoenix Automated System and MicroScan Walkaway System for the Identification and Susceptibility Testing of Clinically Significant Gram-Positive Organisms 2005 LR890 Comparison of the Vitek Legacy, Vitek 2 Colorimetric AND Phoenix Systems for Identification of Fermenting and Non-Fermenting Bacteria of Clinical Origin 2005 LR885 Clinical Evaluation Comparing the BD Phoenix™ Automated Microbiology System with the MicroScan® WalkAway for Identification and Antimicrobial Susceptibility Testing of Staphylococcus aureus and Enterococcus species 2005 LR898 Accuracy of Identification in BD Phoenix™ Using the New Low Inoculum Mode 2005 LR884 Detection of Oxacillin Resistance in Staphylococcus aureus: Comparison of Phoenix Oxacillin and Cefoxitin MICs, MicroScan Oxacillin MIC, Oxacillin and Cefoxitin Disk Diffusion, and mecA Gene Detection. 2005 LR222305 Detection of Antimicrobial Resistance in Pseudomonas aeruginosa Using the BD Phoenix Automated Microbiology System 2005 LR883 Detection of mecA-mediated Resistance Using Cefoxitin Disk Diffusion (DD) in a Collection of Staphylococcus aureus (SA) Expressing Borderline Oxacillin MICs 2005 LR222306 Comparison of MicroScan Walk-Away®, Phoenix™ and VITEK-TWO® Microbiology Systems Used in the Identification and Susceptibility Testing of Bacteria 2005 LR900 Variability in In Vitro Susceptibility Test Results for E. coli Isolates and Piperacillin/Tazobactam Using Commercial and Reference AST Methods 2005 LR222304 Performance of BD Phoenix™ in Low Inoculum Mode for the Identification of Frequently Isolated Gram-Positive Cocci 2005 LR873 Identification of Gram-Negative Bacilli in BD Phoenix™ Using the New Low Inoculum Mode 2005 LR874 Detection and Interpretation of Macrolide-Lincosamide-Streptogramin Resistance among Staphylococcus with Phoenix Automated Microbiology System and BDXpert™ System 2005 LR875 Detection of Clindamycin and Erythromycin Resistance in Isolates of Streptococcus agalactiae using Three Commercial Systems 2005 LR882 Comparison of BD Phoenix to Biomerieux Vitek for the Identification and Susceptibility Testing of Common Bacterial Isolates 2005 LR905 Evaluation of the BD Phoenix System for Identification and Susceptibility Testing of Gram-Positive and Negative Clinical Isolates 2005 LR901 Comparison of the BD Phoenix™ (PHX) Automated Microbiology System to VIKTEK 1 (V1) for the Identification and Antimicrobial Susceptibility Testing of Gram-Negative Organisms 2004 LR813 Comparison of Four Commercially Available Systems for Antimicrobial Susceptibility Testing (AST) of Streptococcus pneumoniae 2004 LR811 Evaluation of the Phoenix 100 ID/AST System for Identification of Enterobacteriaceae and Commonly Isolated Glucose Non-Fermenting Gram-Negative Bacilli 2004 LR222340 Comparison of BD Phoenix Automated Microbiology System with the MicroScan Rapid Neg ID Plus Neg MIC Panel Type 30 for Identification and Susceptibility Testing of Gram-negative Bacilli 2004 LR812 Evaluation of the Etest ESBL and the BD Phoenix™, Vitek-1, and Vitek-2 Automated Instruments for Detection of Extended-Spectrum Beta-Lactamases in Multiresistant Escherichia coli and Klebsiella spp. 2002 LR741 Comparative Evaluation of the BD Phoenix and Vitek 2 Automated Instruments for Identificaiton of Isolates of the Burkholderia cepacia Complex 2002 LR732 An Evaluation of the BD Phoenix™ Automated Microbiology System to Detect Penicillins and Cephalosporins Resistance in Streptococcus pneumoniae 2002 LR738 Side by Side by Side Evaluation of Dade Microscan Walkaway 96, BD Phoenix™ and BioMerieux Vitek2 for Identification Testing of a Challenge and Routine Set of Nonfermentative and Miscellaneous Gram Negative Clinical Isolates 2002 LR726 Side by Side by Side Evaluation of Dade Microscan Walkaway 96, BD Phoenix™ and BioMerieux Vitek2 for Antimicrobial Susceptibility Testing of a Challenge Set of Clinical Strains 2002 LR727 Identification and Antimicrobial Susceptibility Testing of Clinical Isolates of Nonfermenting Gram-Negative Bacteria by the Phoenix™ Automated Microbiology System 2002 LR737 Detection of Vancomycin Resistance in Enterococci with the BD Phoenix™ Automated Microbiology System 2002 LR725 Detection of Extended Spectrum Beta-Lactamase Among Enterobacteriaceae Using BD Phoenix™ Automated Microbiology System with BDXpert™ System 2002 LR739 Correlation Between Phenotypic and Genotypic Traits of Glycopeptide Susceptible and Resistant Enterococcus faecium Strains 2002 LR723 Comparison of the BD Phoenix™ Automated Microbiology System to the Dade-MicroScan WalkAway-40 for Identification of Clinical Bacterial Isolates 2002 LR714 Comparison of the BD Phoenix™ Automated Microbiology System to the Dade-MicroScan WalkAway-40 for Antimicrobial Susceptibility Testing with Gram-Negative and Gram-Positive Bacterial Isolates 2002 LR713 Comparison of Phoenix to Vitek2 with a Diverse Group of Bacteria which are Found in Clinical Microbiology Labs 2002 LR719 Investigation of Staphylococcus aureus with Vitek-1 Erythromycin-Intermediate Susceptibilities: Comparison with Vitek-2 and Phoenix™ 2002 LR740 Comparison of Phoenix to Vitek2 Antimicrobial Susceptibility Test Performance with a Diverse Group of Bacteria which are Found in Clinical Microbiology Labs 2002 LR718 Antimicrobial Susceptibility Testing for Ten 5-Fluoroquinolones Using the BD Phoenix™ Automated Microbiology System 2002 LR717 Evaluation of the Phoenix™ and Vitek 2® Systems for the Susceptibility Testing of Staphylococci 2002 LR728 Evaluation of the BD Phoenix™ Automated Microbiology System for Fluoroquinolone Susceptibility Testing of Gram Negative Bacilli 2002 LR729 Detection of Glycopeptide Intermediate or Resistant Staphylococcus aureus Strains Using BD Phoenix™ Automated Microbiology System 2002 LR724 Evaluation of the New Automated Phoenix™ System for Detection of Special Resistance Mechanisms 2001 LR711 Detection of Oxacillin Resistance in Coagulase Negative Staphylococci with Phoenix™ 2001 LR710 Evaluation of the BD Phoenix™ Automated Microbiology System in Identification and AST of Clinical Isolates of Pseudomonas spp. and Other Nonfermenting Gram-negative Bacteria 2001 LR690 Evaluation of the BD Phoenix™ Automated Microbiology System in Detecting Glycopeptide Resistance Among Enterococci Isolates 2001 LR722 Identification Accuracy of Gram-Negative Bacilli in the BD Phoenix™ Automated Microbiology System 2001 LR686 Evaluation of the Performance of New Phoenix™ Automated Microbiology System on Gram-Negative Rods 2001 LR680 Detection of Resistance to Broad Spectrum β-Lactam Antimicrobics in Nonfermentative Gram-Negative Bacteria Using the BD Phoenix™ Automated Microbiology System 2001 LR688 Detection of Exteded-Spectrum Beta-Lactamase Production and Beta-Lactam Resistance in Escherichia coli and Klebsiella Using the BD Phoenix™ Automated Microbiology System 2001 LR685 Correlation Between Phenotypic Characteristics and Glycopeptide Susceptibility in Enterococcus faecium 2001 LR687 The Importance of Extended-Spectrum β-Lactamase (ESBL) Screening Tests in Rapid Automated Antimicrobial Susceptibility Testing (AST) 2001 LR704 Performance of the BD Phoenix™ Automated Microbiology System in the Identification of Gram-Positive Bacteria 2001 LR684 Evaluation of the New Phoenix™ Automated Microbiology System on Gram-Positive Cocci 2001 LR681 Evaluation of the BD Phoenix™ Automated Microbiology System's Susceptibility Test Function for Gram Positive Organisms 2001 LR697 Antimicrobial Susceptibility Testing and ESBL Production in Clinical Isolates of Proteus Mirabilis: An Evalution with the BD Phoenix™ Automated Microbiology System 2001 LR689 Detection of ESBL Producing E.coli and Klebsiella in the Phoenix™ Automated Microbiology System 2000 LR647 An Evaluation of the Phoenix™ Automated Microbiology System for Extended Spectrum Beta-Lactamase Detection 2000 LR654 Rapid Identification of Resistant Gram-Negative Isolates in the Phoenix™ Automated Microbiology System 2000 LR646 Evaluation to Detect Gram-Negative Bacterial Resistances with Eight Broad-Spectrum Antimicrobics in the Phoenix™ Automated Microbiology System 2000 LR643 Evaluation of the Phoenix™ Automated Microbiology System for the Detection of Gram-Negative Bacterial Resistance to Aminoglycosides 2000 LR648 Determining Beta-Lactam Resistance among Gram-Negative Isolates in the Phoenix™ Automated Microbiology System 2000 LR649 Detection of High Level Aminoglycoside Resistance (HLAR) in Enterococci with the Phoenix™ Automated Microbiology System 2000 LR652 Detection of Resistance to Beta-lactam Antibiotics in Combination with Beta-Lactamase Inhibitors in Gram-Negative Bacteria by the Phoenix™ Automated Microbiology System 2000 LR655 Comparison of the Phoenix™ Automated Microbiology System and MicroScan WalkAway®-96 for In Vitro Susceptibility Testing of Gram-Negative Bacilli 2000 LR653 Assessment of the Phoenix™ Automated Microbiology System in the Identification of a Variety of Gram-Negative Bacilli 2000 LR645 Comparison of Phoenix™ and Vitek® Automated Susceptibility Test Systems for Performance with Acinetobacter baumannii complex and Pseudomonas aeruginosa isolates 2000 LR661 Detection of beta-Lactam Resistance in Staphylococci with the Phoenix™ Automated Microbiology System 2000 LR668 A Performance Evalution of Phoenix™ Automated Microbiology System in detecting resistance to Linezolid, Azithromycin, Clarithromycin and Quinupristin-dalfopristin among Staphylococcal and Enterococcal isolates 2000 LR667 Evaluation of the Phoenix™ Automated Microbiology System for Detection of (i) Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella spp., and of (ii) Ciprofloxacin-Resistant Acinetobacter spp. and Pseudomonas aeruinosa European Clinical Isolates 2000 LR669 Rapid Automated Identification of Gram-Positive and Gram-Negative Bacteria in the Phoenix™ System 1999 LR650 Rapid Antimicrobial Susceptibility Testing in Phoenix™ 1999 LR651 Identification of Gram-Negative Bacteria in the Phoenix™ System 1999 LR638 Rapid Susceptibility Testing of Gram Positive Organisms: A Preliminary Study of the Phoenix™ System 1999 LR641 Detection of Oxacillin Resistance in Staphylococcal Species with the Phoenix™ Sytem 1999 LR635 Rapid Detection of Beta-lactamase Production in Penicillin Sensitive Staphylococci by the Phoenix™ Automated ID/AST System 1999 LR642 Detection of Vancomycin (VA) Resistance in Enterococci with the Phoenix™ System 1999 LR636 Preliminary Evaluation and Overview of Phoenix™, A New Automated ID/AST System 1999 LR637 Comparative Studies of Antibiotic Susceptibility of Stenotrophomonas maltophilia with Trimethoprim/Sulfonamethoxazole Using Different Testing Methodologies 1999 LR640 Antibiotic Susceptibility Testing of Stenotrophomonas maltophilia with Trimethorpim/Sulfamethoxazole Using the Phoenix™ System 1999 LR639 Detection of Gram-Negative Bacterial Resistance to Fluoroquinolone Agents in the Phoenix™ Automated Microbiology System 1999 LR656

Miscellaneous/Discontinued

(Click column headings to sort items)

Description Year Literature # Screening for Nasal Carriage of Methicillin-Resistant Staphylococcus aureus (MRSA): Reduction of Turnaround Time and Workload by the use of BBL™ CHROMagar™ MRSA. 2007 LR222707 Comparison of the IDI-MRSA™ Assay to Culture Using BBL™ CHROMagar™ MRSA for Detection of MRSA from Nasal Surveillance Cultures in an At-Risk Population 2007 LR222708 Enhanced Detection of Methicillin Resistant Staphylococcus aureus Using Chromogenic MRSA Media Compared to Traditional Culture Methods 2005 LR897 Reliability of Coagulase Testing from BBL™ CHROMagar™ MRSA 2005 LR893 The Ability of BBL CHROMagar MRSA to Detect Community-Associated Methicillin Resistant S. aureus 2005 LR895 Evaluation of BBL™ CHROMagar™ MRSA for Detection of Methicillin-Resistant Staphylococcus aureus from Surveillance Swabs 2005 LR889 Comparison of Two Prototypes of BBL™ CHROMagar™ MRSA to Conventional Media for the Detection of Methicillin Resistant Staphylococcus aureus in Clinical Samples 2004 LR805 Detection of Methicillin-Resistant Staphylococcus aureus Using a New Medium, BBL™ CHROMagar™ MRSA, Compared to Current Methods 2004 LR803

Molecular Diagnostics

(Click column headings to sort items)

Description Year Literature # BD Viper™ System with XTR™ Technology Time Study Comparing the Non-Extracted and Extracted Modes for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae 2010 LR223242 A Comparison of CT/GC Results on the BD Viper™ System with XTR™ Technology Using Non-extracted vs. Extracted Modes 2010 LR223241 Repeatability Evaluation of Specimens Tested with the BD ProbeTec™ CT/GC Qx Amplified DNA Assays on the BD Viper™ System with XTR Technology 2009 LR222993 Evaluation of the BD ProbeTec CTQ Amplified DNA Assay for Detection of the New Chlamydia trachomatis Variant in Sweden 2009 LR222995 Analytical Reproducibility of the BD Viper™ System with XTR™ Technology (extracted mode) for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae When Using the BD ProbeTec™ CT/GC Qx Amplified DNA Assays 2009 LR222994 Performance of PreservCyt® Solution Specimens on the BD Viper™ System with XTR™ Technology Utilizing the BD ProbeTec™ Chlamydia trachomatis (CT) Qx Amplified DNA Assay 2009 LR222951 Endocervical Swab Performance from STD Clinics with the BD ProbeTec™ Chlamydia trachomatis (CT) Qx Amplified DNA Assay and the BD ProbeTec™ Neisseria gonorrhoeae (GC) Qx Amplified DNA Assay on the BD Viper™ System with XTR™ Technology (BD Viper System with XTR) 2009 LR222949 Performance of PreservCyt® Solution Specimens on the BD Viper™ System with XTR™ Technology with the BD ProbeTec™ Neisseria gonorrhoeae (GC) Qx Amplified DNA Assay 2009 LR222950 Reproducibility of the BD Viper™ System with XTR™ Technology (Extracted Mode) with PreservCyt® Liquid Based Cytology Medium 2009 LR222944 Performance of SurePath® Preservative Fluid Specimens with the BD ProbeTec CT/GC Qx Amplified DNA Assays on the BD Viper™ System with XTR™ Technology 2009 LR222945 Vaginal Swab Performance on the BD Viper™ System with XTR™ Technology (Extracted Mode) for Detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) at Family Planning / OB/GYN Collection Sites - Perspectives in Clinical Care 2009 LR222943 Performance of the BD ProbeTec&rrade; CT/GC Qx Amplified DNA Assays on the BD Viper™ System with XTR™ Technology Using Male Urine Samples 2009 LR222942 The Measurement of Reliability of the BD Viper™ System 2008 LR222822 Work Flow Efficiencies and Operator Advantages Determined for the BD™ Viper ER and the BD™ ProbeTec 2008 LR222815 Performance of the BD ProbeTec™CT Qx and GC Qx Amplified DNA Assays* with Urine and Vaginal Swab Specimens in the Presence of Potential Interfering Substances 2008 LR222820 Detection of Chlamydia trachomatis and Neisseria gonorrhoeae on Endocervical and Vaginal Swabs with the BD ProbeTec™ CTQx and GCQx Amplified DNA Assays* on the BD Viper™ System in Extracted Mode* 2008 LR222818 Clinical Evaluation of the BD Viper™ System and the BD ProbeTec™ CTQx Amplified DNA Assay (CTQx) for the Direct Qualitative Screening of Chlamydia trachomatis (CT) in Female Endocervical, Female Vaginal, and Female Urine Specimens 2008 LR222814 Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Urine using the BD ProbeTec™ CT Qx and GC Qx Amplified DNA Assays on the BD Viper™ System in Extracted Mode 2008 LR222817 Comparison of Workflow and Analytical Sensitivity with Urine Specimens between the BD ProbeTec™ ET System and the BD Viper™ System in Extracted Mode. 2008 LR222816 Reliability of the BD Viper™ System in Extracted Mode for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae 2008 LR222821 Performance of the BD Viper™ System in Extracted Mode* with the New BD ProbeTec™ Chlamydia trachomatis and Neisseria gonorrhoeae Qx Amplified DNA Assays* 2008 LR222813 Evaluation of the BD Viper™ System in Extracted Modeto Detect Chlamydia trachomatis and Neisseria gonorrhoeae in BD SurePath™ and Preservcyt® Cytology Specimens 2008 LR222819 Evaluation of the BD Viper™ System in Extracted Mode* to Detect Chlamydia trachomatis and Neisseria gonorrhoeae in Male Swab and Urine Specimens 2008 LR222812 Performance of the BD ProbeTec™ CT Qx and GC Qx Amplified DNA Assays with PreservCyt&red; Specimens on the BD Viper™ System in Extracted Mode 2008 LR222811 Feasibility of Using TriPath Imaging,® Inc. SurePath™ Preservative Fluid with the BD ProbeTec™ ET CT/GC Amplified DNA Assays* 2005 LR881 Evaluation of the BD ProbeTec™ Urine Preservative Transport (UPT) for Use With the BD ProbeTec™ ET Neisseria gonorrhoeae Amplified Assays 2005 LR887 Evaluation of the BD ProbeTec ET System for Chlamydia trachomatis and Neisseria gonorrhoeae Infections of the Endocervix and Oropharynx in Women 2005 LR902 Compatibility of Accurun® and Amplichek™ Positive Controls with the BD ProbeTec™ ET CT/GC Amplified DNA Assays 2005 LR879 Performance of the BD ProbeTec™ Urine Preservative Transport with Second Generation Amplified DNA Assays for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae on the BD ProbeTec™ ET System 2005 LR907 Detection of Chlamydia trachomatis and Neisseria gonorrhoeae from Vaginal Swabs Using Second Generation Assays on the BD ProbeTec™ ET System 2005 LR910 Validation of the BD ProbeTec™ Urine Preservative Transport (UPT) for use with the BD ProbeTec™ ET System for Detection of Chlamydia Trachomatis 2005 LR908 Time-Motion Comparison of BD ProbeTec™ ET System and Gen-Probe® APTIMA® Combo 2™ Assay for Chlamydial and Gonorrhea Diagnosis 2005 LR903 Detection of Herpes Simplex Virus Type 1 and Type 2 DNA by Strand Displacement Amplification on the BD ProbeTec™ ET System 2005 LR880 Detection of Chlamydia trachomatis and Neisseria gonorrhoeae from Endocervical Swabs: A Comparative Evaluation of Three Commercial Kits 2005 LR906 Detection of Severe Acute Respiratory Syndrome-Associated Coronavirus (SARS-CoV) by Reverse Transcriptase-Strand Displacement Amplification on the BD ProbeTec™ ET System 2004 LR802 Detection of Herpes Simplex Virus Type 1 by Strand Displacement Amplification on the BD ProbeTec™ ET System 2003 LR753 Take Action on HEDIS 2003 LR691 Comparison of the BD ProbeTec ET and Gen Probe PACE 2 Assays for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Endocervical Samples 2003 LR770 Comparison of Two Nucleic Acid Amplification Tests to Culture for the Detection of Pharyngeal 2002 LR716 Detection of Community Acquired Pneumonia Pathogens in Lower Respiratory Specimens Using the BD ProbeTec™ ET System 2002 LR797 BDProbeTec™ ET CT/GC Amplified DNA Assay Wet Swab Transport for use with Endocervical and Urethral Swab 2002 LR730 Comparison of Three Nucleic Acid Amplification Tests for the Detection of Chlamydia trachomatis in Urine Specimens 2002 LR715 Detection of Legionella pneumophila, Mycoplasma pneumoniae, and the Chlamydiaceae Family from a Single Throat Swab Using the BD ProbeTec™ ET System 2002 LR796 Detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) in Pooled Urine and Cervical Swab Specimens by BDProbeTec™ ET. 2001 LR699 Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by Enzyme Immunoassay, Culture, and Three Nucleic Acid Amplification Tests 2001 LR625 Multicenter Evaluation of the BDProbeTec™ ET System for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Urine Specimens, Female Endocervical Swabs, and Male Urethral Swabs 2001 LR679 Detection of Chlamydia pneumoniae and Other Organisms of the Chlamydiaceae Family by Strand Displacement Amplification on the BD ProbeTec™ ET System* 2001 LR795 Evaluation of Vaginal Swab Specimens for Detection of Neisseria gonorrhoeae and Chlamydia trachomatis by BDProbeTec™ ET 2001 LR692 Clinical Comparison of the BDProbeTec™ ET Amplified DNA Assay and the Abbott LCx for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Endocervical Swabs and Urine Samples 2001 LR683 A Long Term Evaluation of the BDProbeTec™ ET System for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in a High Volume Clinical Laboratory 2001 LR709 In-House Verification of the BDProbeTec™ (BDP) Chlamydia trachomatis (CT) and Neisseria gonorrohoeae (NG) Amplified Assay using Abbott LCx (LCX) STD Swab Specimen Collection System 2001 LR693 Performance Comparison of the Becton Dickinson ProbeTec System for Direct Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Male and Female Urine Specimens in Comparison With the Roche Cobas System 2000 LR733 Universal Probes for Homogeneous Real-Time Fluorescent Detection of Strand Displacement Amplification Products 2000 LR623 Strand Displacement Amplification for the Diagnosis of Chlamydia and Gonorrhea in North Queensland 2000 LR664 Evaluation of the BDProbeTec™ ET Assay for Diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae Infections 2000 LR662 Evaluation of the BDProbeTec™ ET System for the Direct Detection of Mycobacterium tuberculosis Complex from Clinical Respiratory Specimens using Strand Displacement Amplification Technology 2000 LR620 Detection of Mycoplasma pneumoniae by Strand Displacement Amplification on the BDProbeTec™ ET System 2000 LR622 Detection of Legionella pneumophila by Strand Displacement Amplification on the BDProbeTec™ ET System 2000 LR624 Detection of Bordetella pertussis by Homogeneous Strand Displacement Amplification for use on the BDProbeTec™ ET System 2000 LR621 Correlation of Three Commercial Nucleic Acid Amplification Techniques and Conventional Assys for Chlamydia trachomatis and Neisseria gonorrhoeae in Female Endocervical Swab and Urine Specimens 2000 LR666 Comparison of BDProbeTec™ ET, Abbott LCx®, Roche COBAS AMPLICOR®, and GenProbe PACE 2® Assays for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Female Urine and Swab Specimens 2000 LR665 Experimental Evaluation of Chlamydia trachomatis and Neisseria gonorrhoeae Detection Sensitivity of BDProbeTec™ ET 2000 LR663 Evaluation of the BDProbeTec™ ET System for N. gonorrhoeae and C. trachomatis Diagnosis Using Urine or Swab Specimens from Females Attending STD Clinics 1999 LR614 Clinical Evaluation of the BDProbeTec™ ET System in Detecting C. Trachomatis and N. Gonorrhoeae in Endocervical and Female Urine Specimens. 1999 LR609 The Development of Three Strand Displacement Amplification Assays for Culture Confirmation of Mycobacterium tuberculosis Complex, Mycobacterium avium Complex and Mycobacterium kansasii on the BDProbeTec™ ET System 1999 LR602 Multicenter Evaluation of the BDProbeTec™ ET System in Detecting Chlamydia trachomatis and Neisseria gonorrhoeae from Endocervical and Urine Specimens in Women 1999 LR613 Evaluation of the BDProbeTec™ ET* System for the Direct Detection of Mycobacterium tuberculosis Complex from Smear Negative Respiratory Samples 1999 LR599 Evaluation of the BDProbeTec™ ET System on Urine and Genital Specimens for the Identification of Chlamydia and Gonorrhea Infections in Adolescents 1999 LR618 Evaluation of the BDProbeTec™ ET System on Urine and Endocervical Specimens for the Identification of Chlamydia and Gonorrhea Infections. 1999 LR612 Evaluation of Swab Interfering Substances on the BDProbeTec™ ET Chlamydia trachomatis and Neisseria gonorrhoeae Amplified DNA Assay 1999 LR604 Evaluation of Room Temperature Storage and Stability of Specimens in the BDProbeTec™ ET System for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae from Female Endocervical and Female and Male Urine Specimens 1999 LR615 Development of a Homogeneous DNA Amplification Test for the Real-Time, Direct Detection of Mycobacterium tuberculosis DNA on the BDProbeTec™ ET Instrument 1999 LR601 Comparison of the BDProbeTec™ ET System to Ligase Chain Reaction and Polymerase Chain Reaction for Detection Chlamydia trachomatis and Neisseria gonorrhoeae 1999 LR611 A Method to Enumerate Chlamydia trachomatis by Counting DFA Stained Elementary Bodies on a Printed Microscope Slide 1999 LR603 Multicenter Evaluation of the BDProbeTec™ ET System in Detecting Chlamydia trachomatis and Neisseria gonorrhoeae from Endocervical and Urine Specimens in Women 1999 LR616 Evaluation of the BDProbeTec™ ET Thermophilic Strand Displacement Assay for the Simultaneous Amplification and Detection of Chlamydia Trachomatis and Neisseria Gonorrhoeae. 1999 LR617 Evaluation of BDProbeTec™ ET for the Detection of Chlamydia Trachomatis and Neisseria Gonorrhoeae in Female Urogenital Specimens 1999 LR610 Effect of Potentially Interfering Substances on the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Urine Samples Using the BDProbeTec™ ET System 1999 LR600 Strand Displacement Amplification and Homogeneous Real-Time Detection Incorporated in a Second-Generation DNA Probe System, BDProbeTecET 1999 LR598 Comparison of the BDProbeTec™ ET System to Ligase Chain Reaction (LCR) for the Detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) 1999 LR619 Evaluation of the BDProbeTec™ ET Oven to Render Microorganisms Nonviable Prior to Testing on the BDProbeTec™ ET System 1997 LR631

Mycobacteria Testing

(Click column headings to sort items)

Description Year Literature # Comparison of the BACTEC MGIT 320 to the BACTEC MGIT 960 for the Growth, Detection and Susceptibility Testing of Mycobacterium tuberculosis. 2010 LR223279 Comparison of clarithromycin susceptibility of Mycobacterium avium complex using the NCCLS BACTEC™ 460 method and the BACTEC™ MGIT™ 960. 2005 LR913 Susceptibility Testing of Mycobacterium tuberculosis to Anti-Tuberculosis Drugs: BACTEC™ MGIT™ 960 vs BACTEC™ 460TB System 2000 LR660

Prepared Media

(Click column headings to sort items)

Description Year Literature # Rapid Identification of Yeast Isolates using BD BBL™ CHROMagar™ Candida 2005 LR894 Isolation of Uropathogens on Chromogenic Agar versus Standard Dipslides from Urine Collected with and without Preservative 2005 LR892 Evaluation of BBL™ CHROMagar™ Orientation Agar for Routine Urine Cultures in a High Volume Clinical Laboratory 2005 LR896 Evaluation of New BBL™ CHROMagar™ Listeria for Isolation of Listeria monocytogenes in Foods 2005 LR916 Evaluation of BBL™ CHROMagar™ Listeria: AOAC Performance Tested MethodSM 2005 LR918 Evaluation of BBL™ CHROMagar™ Salmonella: AOAC Performance Tested MethodSM 2005 LR917 Comparison of BBL™ CHROMagar™ O157 to Sorbitol MacConkey for Recovery of E. coli O157 in Stool Cultures 2004 LR807 Growth Characteristics of Moulds on BBL™ CHROMagar™ Candida Medium 2004 LR810 Use of BBL™ CHROMagar™ Orientation Media for the Identification and Enumeration of Urinary Tract Pathogens: Comparison to Routine Culture Techniques 2004 LR808 The Ability of BBL™ CHROMagar™ Orientation to Recover Corynebacterium urealyticum 2004 LR804 Evaluation of a New Commercially Available Rapid Assimilation of Trehalose (RAT) Test for the Identification of Candida glabrata 2004 LR809 Cost Effectiveness of BBL™ CHROMagar™ Orientation Medium for Routine Urine Cultures 2004 LR806 BBL™ CHROMagar™ Candida as the Sole Primary Medium for the Isolation of Yeasts and as a Source Medium for the Rapid Assimilation of Trehalose (RAT) Test 2003 LR767 BBL™ CHROMagar™ Staph aureus is Superior to Mannitol Salt for Detection of Staphylococcus aureus in Complex Mixed Infections 2003 LR777 Practical Bench Comparison of BBL™ CHROMagar™ Orientation and Standard 2-Plate Media for Urine Cultures 2003 LR766 Comparison of BBL™ CHROMagar™ Listeria to Currently Recommended Media for the Isolation of Listeria monocytogenes from Food Sources 2003 LR915 Comparison of BBL™CHROMagar™ Staph aureus to Conventional Media for the Detection of Methicillin Susceptible and Methicillin Resistant Staphylococcus aureus in Clinical Respiratory Samples 2003 LR765 Comparison of BBL™ CHROMagar™ Staph aureus to other Commonly Used Media for the Presumptive Identification of Staphylococcus aureus 2002 LR745 Evaluation of BBL™ CHROMagar™ Candida as the Primary Isolation Medium for Use With Two Confirmatory Identification Systems, IDS RapID Yeast Plus System and API 20C AUX 2001 LR698